This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "INAVO-PBO Trial - 1L Inavolisib/Placebo + Palbo + Fulv in Patients With PIK3CAm, HR+/HER2‑ Locally Advanced/Metastatic BC Who Relapsed During/Within 12 Months of Adjuvant ET Completion"

By ecancer FEATURING Dejan Juric
By ecancer FEATURING Dejan Juric
131 views
July 2, 2024
Comments 0
Login to view comments. Click here to Login